Gestational Diabetes. Gestational diabetes mellitus
Conditions
Interventions
Intervention 1: The intervention group will receive 4000 units of oral vitamin D daily produced by Dana Pharmaceutical Company, which is quite similar in appearance to the drug used in the placebo g
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Pregnant women with gestational age of 8 -10 weeks Vitamin D levels below 30 ng / ml
Exclusion criteria
Exclusion criteria: Women with diabetes Vitamin D levels above 30 ng / ml Women with thyroid and parathyroid disorders according to the self-report Women with a history of macrosomic neonate Women with a body mass index above 30 kg / m2 before pregnancy Women with pre-pregnancy polycystic ovary syndrome, according to the self-report Women with a history of diabetes or gestational diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Insulin resistance index. Timepoint: Before the intervention - 26 weeks of pregnancy. Method of measurement: HOMA-IR index.;Fasting plasma glucose levels. Timepoint: Before the intervention - 26 weeks of pregnancy. Method of measurement: FBS.;Fasting plasma insulin levels. Timepoint: Before the intervention - 26 weeks of pregnancy. Method of measurement: FBI. | — |
Secondary
| Measure | Time frame |
|---|---|
| Abortion rate. Timepoint: 26 weeks of pregnancy. Method of measurement: Abortion checklist.;Gestational Diabetes. Timepoint: 26 weeks of pregnancy. Method of measurement: OGTT - FBS.;Depression score. Timepoint: 26 weeks of pregnancy. Method of measurement: Edinburgh Depression Questionnaire.;Side effects. Timepoint: 26 weeks of pregnancy. Method of measurement: Side effects checklist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Mirzaee Azandaryani
Tabriz University of Medical Sciences
Outcome results
None listed